Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocell...
Prof Richard Finn - Geffen School of Medicine at UCLA, Los Angeles, USA
Safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma ( Prof Richard Finn - Geffen School of Medicine at UCLA, Los Angeles, USA )
13 Apr 2021
Efficacy and safety of selpercatinib in RET fusion-positive cancers other than l...
Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA
Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )
13 Apr 2021
High-quality neoantigens are immunoedited in long-term survivors of pancreatic c...
Prof Marta Luksza - Tisch Cancer Institute, New York, USA
High-quality neoantigens are immunoedited in long-term survivors of pancreatic cancer ( Prof Marta Luksza - Tisch Cancer Institute, New York, USA )
12 Apr 2021
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
9 Feb 2021
OncoAlert Colloquium Day 1: GI tumours and MASCC
Dr Eng, Dr Cervantes, Dr Janjigian, Dr Lewis, Dr George, Dr Lustberg, Dr Chan, D...
OncoAlert Colloquium Day 1: GI tumours and MASCC ( Dr Eng, Dr Cervantes, Dr Janjigian, Dr Lewis, Dr George, Dr Lustberg, Dr Chan, Dr Scotte )
23 Dec 2020
Targeting a KRAS neoantigen peptide vaccine to DNGR-1 dendritic cells
Dr Rachel Ambler - The Francis Crick Institute, London, United Kingdom
Targeting a KRAS neoantigen peptide vaccine to DNGR-1  dendritic cells ( Dr Rachel Ambler - The Francis Crick Institute, London, United Kingdom )
27 Nov 2020
OncoAlert and ecancer weekly roundup for November 15 - 21, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for November 15 - 21, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
27 Nov 2020
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020
Dr Gil Morgan - Skåne University Hospital, Lund, Sweden
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020 ( Dr Gil Morgan - Skåne University Hospital, Lund, Sweden )
9 Nov 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more...
Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients ( Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA )
4 Nov 2020
Updates in geriatric medical oncology from SIOG meeting
Dr Enrique Soto - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zu...
Updates in geriatric medical oncology from SIOG meeting ( Dr Enrique Soto - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico )
28 Oct 2020
OncoAlert and ecancer weekly roundup for August 17-23 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for August 17-23 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
24 Aug 2020
OncoAlert and ecancer weekly roundup for August 1-8 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for August 1-8 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Aug 2020